EVIO Competitors

EVIO Stock  USD 0.0001  0.00  0.00%   
The company conducts business in the Drug Manufacturers—Specialty & Generic industry (Healthcare sector). Within this framework, EVIO Inc is compared with Nika BioTechnology, Cipher Pharmaceuticals, Benchmark Holdings, Integrated Diagnostics, and Spectral Med, along with other selected peers. Price-to-sales ratios across EVIO's competitors show which names the market values most per dollar of revenue.

Correlation: EVIO vs Profile Solutions Overview

Specify up to 10 symbols:
The mean reversion principle applied to EVIO's suggests that neither prolonged outperformance nor underperformance is permanent. Identifying the root cause of EVIO's price dislocation is essential before acting on a mean reversion signal. The mean reversion tendency in EVIO's price is a well-documented phenomenon in academic research. In many cases, EVIO's price extremes present statistical patterns that have recurred historically.
Hype
Prediction
LowEstimatedHigh
0.000.000124.96
Details
Intrinsic
Valuation
LowRealHigh
0.000.00006324.96
Details
Naive
Forecast
LowNextHigh
0.0000020.000124.96
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.0000920.0000920.000092
Details
No single-company analysis of EVIO Inc is complete without peer benchmarking. A company that looks attractive in isolation may be significantly outperformed by competitors. Standalone analysis captures EVIO's individual story, but peers reveal if it is truly exceptional. Disciplined peer analysis separates conviction-grade insights from superficial EVIO observations.

EVIO Competition Correlation Matrix

Correlation analysis between EVIO Inc and its competitors provides context for understanding whether diversification is real or only superficial inside the same peer group. The useful question is whether competitors are behaving like true alternatives or simply tracking the same sector move with different volatility.

High positive correlations

FGHQFIDGXF
CPHRFNIKA
CMVLFIDGXF
CMVLFFGHQF
CPHRFABTI
EDTXFIDGXF
  

High negative correlations

IDGXFNIKA
FGHQFNIKA
CMVLFNIKA
CMVLFEDTXF
IDGXFCPHRF
CMVLFABTI

Risk-Adjusted Indicators

Strong recent returns in EVIO Pink Sheet do not always mean EVIO Company is outperforming peers on business quality. Without risk-adjusted context, investors may overweight short-term returns and underweight the volatility required to achieve them. These indicators are quantitative in nature and help investors evaluate volatility and risk-adjusted expected returns across different positions.

EVIO Competitive Analysis

How does EVIO measure up against Nika BioTechnology, Alterola Biotech, and Cipher Pharmaceuticals? The financials tell a nuanced story. EVIO operates at a 268,896 scale with 2.4 M flowing through the income statement. EVIO reports a -40.84% net margin, indicating profitability pressure. Market capitalization diverges sharply here: 268,896 versus 10, giving EVIO a clear size advantage. EVIO is dwarfed by Alterola Biotech on market cap at 39.5 M versus 268,896. Top-line revenue favors Cipher Pharmaceuticals by a wide margin: 21.9 M to 2.4 M.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
EVIO NIKA ABTI CPHRF BHCCF IDGXF EDTXF FGHQF CMVLF
 0.00 
0.0001
EVIO
 0.00 
0.76
Nika
 0.00 
0.01
Alterola
 0.42 
12.04
Cipher
 0.00 
0.37
Benchmark
 0.00 
0.64
Integrated
 6.32 
1.01
Spectral
 0.00 
0.15
Frontage
 0.00 
4.40
Cellectis
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Analysis
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Book Value Per Share
Number Of Shares Shorted
Current Liabilities
Total Asset
Debt To Equity
Target Price
Short Ratio
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

EVIO Competition Peer Performance Charts

How to Analyze EVIO Against Peers

EVIO's peer analysis compares EVIO with related companies to put valuation, quality, and risk metrics in context. This helps determine whether recent performance is company-specific or broadly sector-driven. A practical workflow includes:
  • Set a relevant peer group: Include direct competitors and close alternatives with comparable business exposure.
  • Benchmark core financials: Compare profitability, growth, capital structure, and cash flow quality.
  • Check valuation dispersion: Review whether EVIO trades at a premium or discount versus peers and why.
  • Evaluate risk profile: Compare volatility, drawdowns, and correlation to avoid false diversification assumptions.
  • Document the thesis: Record where EVIO leads or lags and what catalysts could close or widen the gap.
Use this as an educational baseline, then validate conclusions with current filings, market conditions, and portfolio objectives.

Peer Comparison Metrics & Methodology

Insider ownership at EVIO is higher than at most peers, which can align management incentives with shareholder interests. EVIO may trade at a premium to peers, but only sustained outperformance justifies the gap long-term. Relative analysis can highlight whether current pricing already reflects peer-group strengths or weaknesses. For peer comparison, EVIO has a market cap of 268.9 K, profit margin of -40.84%.

Reported values for EVIO Inc are derived from periodic company reporting and market reference feeds and then standardized for analysis. Refresh timing depends on source availability.

This content is curated and reviewed by:

Michael Smolkin - Member of Macroaxis Board of Directors
Last reviewed on March 18th, 2026